Bulls Pick Up Merck Stock After Surprise Quarterly Win

Merck & Co Inc (NYSE:MRK) announced surprise fourth-quarter profits of 3 cents per share earlier, as well as revenue of $14.63 billion, both of which easily surpassed analysts' expectations. Strong demand for cancer drug Keytruda, as well as its HPV vaccine Gardasil contributed to the upbeat results. MRK is up 2.4% to trade at $123.58 at last check, and earlier surged to an all-time high of $125.75. The shares are now on track for their fifth win in the last six trading sessions, with long-term support stem ...